Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy

Background: The Supreme healing-targeted drug-eluting stent (DES) is designed to promote endothelial healing to reduce stent-related adverse events. This may be particularly relevant among complex lesions that have a higher rate of adverse events. We sought to compare 1-year outcomes of percutaneous...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Kush P. Patel, MBBS, Alexandra J. Lansky, MD, Dean J. Kereiakes, MD, Stephan Windecker, MD, Ecaterina Cristea, MD, Cody Pietras, BA, Ovidiu Dressler, MD, M. Ozgu Issever, MS, Michael Curtis, MD, Barry Bertolet, MD, James P. Zidar, MD, Pieter C. Smits, MD, Victor Alfonso Jiménez Díaz, MD, Brent McLaurin, MD, David A. Brogno, MD, Luc Janssens, MD, Mathias C. Vrolix, MD, Iván Gómez-Blázquez, MD, Zakir H. Sahul, MD, Ameer Kabour, MD, Luisa Salido, MD, Michael Cleman, MD, Shigeru Saito, MD, Martin B. Leon, MD, Andreas Baumbach, MD
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2022-01-01
Cyfres:	Journal of the Society for Cardiovascular Angiography & Interventions
Pynciau:	Drug-eluting stent Percutaneous coronary intervention Coronary revascularization Coronary artery disease Acute coronary syndrome
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2772930321000041
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!